Clinical Trial Update: Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial [NA]

View source ↗

Summary

A prospective randomized trial comparing a proton pump inhibitor with an H2 receptor blocker to prevent bleeding after endoscopic submucosal dissection for gast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Neoplasms

Drugs mentioned

• H2 Receptor Blocker
• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Samsung Medical Center | Conditions: Delayed Bleeding | NA | Status: UNKNOWN